{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-004378","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.994007+00:00","generated_at":"2026-06-19T01:34:30.887173+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"LeMaitre Q4 sales up 8% organic; EPS $0.25 (-9%); dividend raised 12% to $0.14; $25M buyback authorized","bullets":["Q4 sales $41.0M (+4% reported, +8% organic); net income $5.6M (-9%); EPS $0.25 (-9%).","Gross margin 63.6% vs 65.7% (150 bps FX headwind); op income $7.0M (-16%).","Quarterly dividend raised 12% to $0.14/share, payable March 23 to record March 9.","Board authorized $25M share repurchase program through Feb 21, 2024.","Q1 2023 guidance: sales $42.6-45.0M (mid +11% reported, +13% organic); EPS $0.22-0.27."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-004378","json":"https://secwatch.observer/filing/0001437749-23-004378.json","markdown":"https://secwatch.observer/filing/0001437749-23-004378.md","text":"https://secwatch.observer/filing/0001437749-23-004378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923004378/0001437749-23-004378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923004378/lmat20230223_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T01:34:30.887173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"94632dcfa102b91b1623ffbba50355cb7e276eba","claim":"LEMAITRE VASCULAR INC reported the quarter ended December 31, 2022 results: revenue $41.0mm, net income $5.6mm, EPS $0.25. Guidance initiated.","evidence_excerpt":"implants and services, today reported Q4 2022 results, announced a $0.14/share quarterly dividend (+12%) and provided guidance. Q4 2022 Financial Results ● Sales $41.0mm, +4% (+8% organic) vs. Q4 2021 ● Op. income $7.0mm, -16% ● Op. margin 17% ● Net income $5.6mm, -9% ● Earnings per diluted share $0.25, -9% ●","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923004378/0001437749-23-004378-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2022"},{"label":"Revenue","value":"$41.0mm"},{"label":"Net income","value":"$5.6mm"},{"label":"EPS","value":"$0.25"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}